Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (8)

« Back to Publications

Programmable RNA editing with endogenous ADAR enzymes – a feasible option for the treatment of inherited retinal disease?

Bellingrath J-S. et al, (2023), Frontiers in Molecular Neuroscience, 16

Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic CRB1 single nucleotide variant.

Bellingrath J-S. et al, (2022), Ophthalmic Genet, 43, 661 - 670

In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention.

Bellingrath J-S. et al, (2021), Genes (Basel), 12

Laparoscopic liver resection in Caroli disease

Wabitsch S. et al, (2021), Journal of Minimal Access Surgery, 17, 63 - 68

Minimally Invasive Liver Surgery in Elderly Patients—A Single-Center Experience

Wabitsch S. et al, (2019), Journal of Surgical Research, 239, 92 - 97

High Symmetry of Visual Acuity and Visual Fields in RPGR-Linked Retinitis Pigmentosa

Bellingrath J-S. et al, (2017), Investigative Opthalmology & Visual Science, 58, 4457 - 4457

Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa

Fischer MD. et al, (2017), Molecular Therapy, 25, 1854 - 1865

Gentherapie als Behandlungskonzept für erbliche Netzhauterkrankungen

Bellingrath J-S. and Fischer MD., (2015), Der Ophthalmologe, 112, 720 - 727